Biomedical Research Institute;
Korea Institute of Science and Technology(KIST);
Seoul 02792;
Republic of Korea;
KU-KIST Graduate School of Converging Science and Technology;
Korea University;
Seoul 02841;
Republic of Korea;
cathepsin B; prodrug; chemotherapy; drug delivery system; targeted cancer therapy;